Short report: 4-Aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome
Håkan Lundh, Ola Nilsson, I. Rosén
Abstract
Open-access reader
Håkan Lundh, Ola Nilsson, I. Rosén
Abstract
Open-access reader
A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.
OpenAlex reports 111 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.
Key concepts: Lambert-Eaton myasthenic syndrome, 4-Aminopyridine, Neuromuscular transmission, Medicine, Drug, Weakness, Anesthesia, Pharmacology